Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation

作者：Xiaoye Li, Zhi‐Chun Gu, Zi Wang, Qing Xu, Chun-Lai Ma, Qianzhou Lv · 发表于：Cardiovascular Drugs and Therapy · 年份：2023 · DOI：10.1007/s10557-023-07495-4 · 被引用次数：15 · 研究领域：Atrial Fibrillation Management and Outcomes、Pharmacogenetics and Drug Metabolism、Antiplatelet Therapy and Cardiovascular Diseases